CTC Detection Rate in SCCHN With a in Vivo Device

Nanjing Tongren Hospital

Status: Unknown

Conditions: Squamous Cell Carcinoma of the Head and Neck; Circulating Tumor Cell

Treatments: Diagnostic Test: circulating tumor cell analysis

Study type: Interventional

Funder types: Other

Identifiers

NCT03071900

NJTRH_CellColletor01

Details and patient eligibility

About

Detection rate and isolation yield of CTC is low in squamous cell carcinoma of head and neck (SCCHN) with in vitro approaches rely on limited sample volumes. In this study, we applied a new method, the CellCollector, which could capture CTC in vivo from peripheral blood.

Enrollment: 50 estimated patients

Sex: All

Ages: 20 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• SCCHN confirmed with clinical examination
• Have agreed to undergo CTC analysis in vivo;
• ECOG：0-2

Exclusion criteria

• the other cancer types

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

50 participants in 2 patient groups

SCCHN

Experimental group

Description:

squamous cell carcinoma of the head and neck

Treatment:

Diagnostic Test: circulating tumor cell analysis

Control

Experimental group

Description:

health volunteers

Treatment:

Diagnostic Test: circulating tumor cell analysis